BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36647673)

  • 1. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
    Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
    PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
    Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
    Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.
    Ito S; Nagoshi N; Kamata Y; Kojima K; Nori S; Matsumoto M; Takei K; Nakamura M; Okano H
    Stem Cell Reports; 2021 Nov; 16(11):2703-2717. PubMed ID: 34653401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
    Shibata R; Nagoshi N; Kajikawa K; Ito S; Shibata S; Shindo T; Khazaei M; Nori S; Kohyama J; Fehlings MG; Matsumoto M; Nakamura M; Okano H
    J Neurotrauma; 2022 May; 39(9-10):667-682. PubMed ID: 35196890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
    Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
    Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
    Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
    Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
    Kamata Y; Isoda M; Sanosaka T; Shibata R; Ito S; Okubo T; Shinozaki M; Inoue M; Koya I; Shibata S; Shindo T; Matsumoto M; Nakamura M; Okano H; Nagoshi N; Kohyama J
    Stem Cells Transl Med; 2021 Mar; 10(3):398-413. PubMed ID: 33226180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Nakamura M; Okano H; Nagoshi N
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
    Okubo T; Iwanami A; Kohyama J; Itakura G; Kawabata S; Nishiyama Y; Sugai K; Ozaki M; Iida T; Matsubayashi K; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2016 Oct; 7(4):649-663. PubMed ID: 27666789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Recovery from Neural Stem/Progenitor Cell Transplantation Combined with Treadmill Training in Mice with Chronic Spinal Cord Injury.
    Tashiro S; Nishimura S; Iwai H; Sugai K; Zhang L; Shinozaki M; Iwanami A; Toyama Y; Liu M; Okano H; Nakamura M
    Sci Rep; 2016 Aug; 6():30898. PubMed ID: 27485458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of regenerative therapy for spinal cord injury using human iPS cells.
    Kawai M; Nagoshi N; Okano H; Nakamura M
    N Am Spine Soc J; 2023 Mar; 13():100184. PubMed ID: 36479183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
    Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
    PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.
    Kong D; Feng B; Amponsah AE; He J; Guo R; Liu B; Du X; Liu X; Zhang S; Lv F; Ma J; Cui H
    Stem Cell Res Ther; 2021 Mar; 12(1):172. PubMed ID: 33706803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.
    Iwai H; Nori S; Nishimura S; Yasuda A; Takano M; Tsuji O; Fujiyoshi K; Toyama Y; Okano H; Nakamura M
    Cell Transplant; 2014; 23(11):1451-64. PubMed ID: 23998989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor pretreatment boosts functional recovery after spinal cord injury through human iPSC-derived neural stem/progenitor cell transplantation.
    Suematsu Y; Nagoshi N; Shinozaki M; Kase Y; Saijo Y; Hashimoto S; Shibata T; Kajikawa K; Kamata Y; Ozaki M; Yasutake K; Shindo T; Shibata S; Matsumoto M; Nakamura M; Okano H
    Inflamm Regen; 2023 Oct; 43(1):50. PubMed ID: 37845736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates.
    Iwai H; Shimada H; Nishimura S; Kobayashi Y; Itakura G; Hori K; Hikishima K; Ebise H; Negishi N; Shibata S; Habu S; Toyama Y; Nakamura M; Okano H
    Stem Cells Transl Med; 2015 Jul; 4(7):708-19. PubMed ID: 26019226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model.
    Nutt SE; Chang EA; Suhr ST; Schlosser LO; Mondello SE; Moritz CT; Cibelli JB; Horner PJ
    Exp Neurol; 2013 Oct; 248():491-503. PubMed ID: 23891888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
    Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
    Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets.
    Yamane J; Nakamura M; Iwanami A; Sakaguchi M; Katoh H; Yamada M; Momoshima S; Miyao S; Ishii K; Tamaoki N; Nomura T; Okano HJ; Kanemura Y; Toyama Y; Okano H
    J Neurosci Res; 2010 May; 88(7):1394-405. PubMed ID: 20091712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.